Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in Well-Differentiated Thyroid Cancer Diagnosed in 2000–2010
Background. Use of radioactive iodine (RAI) ablation has been reported to vary significantly between studies. We explored variation in RAI ablation care patterns between seven thyroid cancer treatment centers in Canada. Methods. The Canadian Collaborative Network for Cancer of the Thyroid (CANNECT)...
Main Authors: | I. Rachinsky, M. Rajaraman, W. D. Leslie, A. Zahedi, C. Jefford, A. McGibbon, J. E. M. Young, K. A. Pathak, M. Badreddine, S. De Brabandere, H. Fong, S. Van Uum |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Thyroid Research |
Online Access: | http://dx.doi.org/10.1155/2016/2867916 |
Similar Items
-
Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
by: Fabián Pitoia, et al.
Published: (2012-01-01) -
Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
by: Lv RB, et al.
Published: (2017-08-01) -
Performance of the American Thyroid Association Risk Classification in a Single Center Cohort of Pediatric Patients with Differentiated Thyroid Cancer: A Retrospective Study
by: Raad Alwithenani, et al.
Published: (2019-01-01) -
Radioiodine Remnant Ablation: A Critical Review
by: Chandra Sekhar Bal, et al.
Published: (2015-01-01) -
Radioiodine and thyroid gland
by: Takavar A
Published: (1994-05-01)